Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes

Journal of Steroid Biochemistry and Molecular Biology

Volumn 113, Issue 1-2, 2009, Pages 17-24

  Szkudelska, Katarzyna ^a   Nogowski, Leszek ^a   Szkudelski, Tomasz ^a  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Adipocytes; Metabolism; Resveratrol

Indexed keywords

ADRENALIN; BUCLADESINE; CARBON DIOXIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTROGEN RECEPTOR; GLUCOSE; GLYCEROL; INSULIN; LACTIC ACID; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; RESVERATROL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; GLUCOSE METABOLISM; LIPOGENESIS; LIPOLYSIS; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; RAT;

ADIPOCYTES; ANIMALS; BUCLADESINE; CARBON DIOXIDE; CELL SEPARATION; CELL SURVIVAL; CYCLIC AMP; EPINEPHRINE; FATTY ACIDS; GLYCEROL; INSULIN; ISOQUINOLINES; LACTIC ACID; LIPOGENESIS; LIPOLYSIS; MALE; PHENOLS; RATS; RATS, WISTAR; STILBENES; SULFONAMIDES;

RATTUS;

EID: 59849106498     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.11.001     Document Type: Article

References (49)

1. Nonomura S., Kanagawa H., and Makimoto A. Chemical constituents of polygonaceous plants. Studies on the components of Ko-jo-kon (Polygonum cuspidatum-Sieb et Zucc). Yakugaku Zasshi 83 (1963) 988-990
2. Kubo M., Kimurta Y., Shin H., Haneda T., Tani T., and Namba L. Studies on the anti-fungal substances of crude drug (II). On the roots of Polygonum cuspidatum Sieb et Zucc (Polygonaceae). Shoyakugaku Zasshi 35 (1981) 58-61
3. Sieman E.H., and Creasy L.L. Concentration of the phytoalexin resveratrol in wine. Ann. J. Eno. Vitic. 43 (1992) 49-52
4. Carbó N., Costelli P., Baccino F.M., López-Soriano F.J., and Argilés J.M. Resveratrol, a natural product present in wine, decreases tumor growth in a rat tumor model. Biochem. Biophys. Res. Commun. 254 (1999) 739-743
5. Pervaiz S. Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol. Drug Resist. Updat. 7 (2004) 333-344
6. Sun W., Wang W., Kim J., Keng P., Yang S., Zhang H., Liu C., Okunieff P., and Zhang L. Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment. Adv. Exp. Med. Biol. 14 (2008) 179-186
7. Miller N.J., and Rice-Evans C.A. Antioxidant activity of resveratrol in red wine. Clin. Chem. 42 (1995) 1789
8. Das S., and Das D.K. Anti-inflammatory responses of resveratrol. Inflamm. Allergy Drug Targets 6 (2007) 168-173
9. Hung L.M., Chen J.K., Huang S.S., Lee R.S., and Su M.J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47 (2000) 549-555
10. Bradamante S., Barenghi L., Piccini F., Bertelli A.A., De Jonge R., Beemster P., and De Jong J.W. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur. J. Pharmacol. 465 (2003) 115-123
11. Bowers J.L., Tyulmenkov V.V., Jernigan S.C., and Klinge C.M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141 (2000) 3657-3667
12. Arichi H., Kimura Y., Okuda H., Baba K., Kozawa M., and Arichi S. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem. Pharm. Bull. 30 (1982) 1766-1770
13. Sharma S., Anjaneyulu M., Kulkarmi S.K., and Chopra K. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 76 (2006) 69-75
14. Su H.C., Hung L.M., and Chen J.K. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 290 (2006) 1339-1346
15. Szkudelski T. Resveratrol inhibits insulin secretion from rat pancreatic islets. Eur. J. Pharmacol. 55 (2006) 176-181
16. Szkudelski T. Resveratrol-induced inhibition of insulin secretion from rat pancreatic islets: evidence for pivotal role of metabolic disturbances. Am. J. Physiol. Endocrinol. Metab. 293 (2007) 901-907
17. Szkudelski T. The insulin-suppressive effect of resveratrol-an in vitro and in vivo phenomenon. Life Sci. 82 (2008) 430-435
18. Chen W.P., Chi T.C., Chuang L.M., and Su M.J. Resveratrol enhances insulin secretion by blocking KATP and KV channels of beta cells. Eur. J. Pharmacol. 568 (2007) 269-277
19. Chi T.C., Chen W.P., Chi T.L., Kuo T.F., Lee S.S., Cheng J.T., and Su M.J. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci. 80 (2007) 1713-1720
20. Baur J.A., Pearson K.J., Price N.L., Jamieson N.L., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., and Sinclair D.A. Resveratrol improves health and survival of mice on high-calorie diet. Nature 444 (2006) 337-342
21. Lagouge M., Argmann C., Grhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott B., Geny M., Laakso P., Puigserver J., and Auwerx. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127 (2006) 1-14
22. Rodbell M. Metabolism of isolated fat cells. J. Biol. Chem. 239 (1964) 375-380
23. Szkudelska K., Nogowski L., and Szkudelski T. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J. Steroid Biochem. Mol. Biol. 75 (2000) 265-271
24. Dole V.P., and Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissues. J. Biol. Chem. 235 (1960) 2595-2599
25. Everse J. Enzymic determination of lactic acid. Methods Enzymol. 41 (1975) 41-44
26. Foster L.B., and Dunn R.T. Stable reagents for determination of serum triglicerides by a colorimetric Hantzsch condensation. Clin. Chem. 19 (1973) 338-340
27. Duncombe D. The colorimetric micro-determination of nonesterified fatty acids in plasma. Clin. Chim. Acta 9 (1964) 122-125
28. Zhang J. Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem. J. 397 (2006) 519-527
29. Slater S.J., Seiz J.L., Cook A.C., Stagliano B.A., and Buzas C.J. Inhibition of protein kinase C by resveratrol. Biochim. Biophys. Acta 1637 (2003) 59-69
30. El-Mowafy A.M., Alkhalaf M., and El-Kashef H.A. Resveratrol reverses hydrogen peroxide-induced proliferative effects in human coronary smooth muscle cells: a novel signaling mechanism. Arch. Med. Res. 39 (2008) 155-161
31. Smal J., and de Meyts P. Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 4705-4709
32. Egan J.J., Greenberg A.S., Chang M.K., and Londos C. Control of endogenous phosphorylation of the major cAMP-dependent protein kinase substrate in adipocytes by insulin and beta-adrenergic stimulation. J. Biol. Chem. 265 (1990) 18769-18775
33. Zini R., Morin C., Bertelli A., Bertelli A.A., and Tillement J.P. Resveratrol-induced limitation of dysfunction of mitochondria isolated from rat brain in an anoxia-reoxygenation model. Life Sci. 71 (2002) 3091-3108
34. Zheng J., and Ramirez V.D. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol. 130 (2000) 1115-1123
35. Flatt J.P. Conversion of carbohydrate to fat in adipose tissue: an energy-yielding, and, therefore, self-limiting process. J. Lipid Res. 11 (1970) 131-143
36. Londos C., Brasaemle D.L., Schultz C.J., Adler-Wailes D.C., Levin D.M., Kimmel A.R., and Rondinone C.M. On the control of lipolysis in adipocytes. Ann. N.Y. Acad. Sci. 892 (1999) 155-168
37. El Mowafy A.M., and Alkhalaf M. Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 24 (2003) 869-873
38. Blumenstein I., Keserü B., Wolter F., and Stein J. The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitro. Clin. Cancer Res. 11 (2005) 5651-5656
39. Elks M.L., and Manganiello V.C. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation. Endocrinology 116 (1985) 2119-2121
40. Eriksson H., Ridderstrale M., Degerman E., Ekholm D., Smith C.J., Manganiello V.C., Belfrage P., and Tornqvist H. Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin. Biochim. Biophys. Acta 1266 (1995) 101-107
41. Szkudelski T., Nowicka E., and Szkudelska K. Leptin secretion and protein kinase A activity. Physiol. Res. 54 (2005) 79-85
42. Raclot T., and Oudart H. Net release of individual fatty acids from white adipose tissue during lipolysis in vitro: evidence for selective fatty acid re-uptake. Biochem. J. 348 (2000) 129-136
43. Wang T., Zang Y., Ling W., Corkey B.E., and Guo W. Metabolic partitioning of endogenous fatty acid in adipocytes. Obes. Res. 11 (2003) 880-887
44. Szkudelski T., Lisiecka M., Nowicka E., Kowalewska A., Nogowski L., and Szkudelska K. Short-term fasting and lipolytic activity in rat adipocytes. Horm. Metab. Res. 36 (2004) 667-673
45. Wang M.Y., Lee Y., and Unger R.H. Novel form of lipolysis induced by leptin. J. Biol. Chem. 274 (1999) 17541-17544
46. Lei T., Xie W., Han J., Corkey B.E., Hamilton J.A., and Guo W. Medium-chain fatty acids attenuate agonist-stimulated lipolysis, mimicking the effects of starvation. Obes. Res. 12 (2004) 599-611
47. Klinge C.M., Blankenship K.A., Risinger K.E., Bhatnager S., Noision E.L., Sumanasekera W.K., Zhao L., Brey D.M., and Keynton R.S. Resveratrol and estradiol rapidly activate MAPK signalling through estrogen receptors alpha and beta in endothelial cells. J. Biol. Chem. 280 (2005) 7460-7468
48. Liew R., Stagg M.A., MacLeod K.T., and Collins P. The red wine poliphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes. Eur. J. Pharmacol. 519 (2005) 1-8
49. Matsumura A., Ghosh A., Pope G.S., and Darbre P.D. Comparative study of estrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 94 (2005) 431-443